Effect of Artronat on the Quality of Life of Patient With Osteoarthritis

• Register: ClinicalTrials.gov
• Last refreshed on: 19 February 2015
• Main ID: NCT01356199
• Date of registration: 17/05/2011
• Prospective Registration: Yes
• Primary sponsor: Lescuyer Laboratory
• Public title: Effect of Artronat on the Quality of Life of Patient With Osteoarthritis
• Scientific title: Effet du complément Alimentaire ARTRONAT(R) Sur la réduction de la Gonalgie Chez Des Sujets Arthrosiques
• Date of first enrolment: October 2011
• Target sample size: 7
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT01356199
• Study type: Interventional
• Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care
• Phase: N/A

Countries of recruitment

France

Contacts

• Name: Dominique Baron, MD
• Affiliation: Hospital Center of Lanion

• Name: Maurice Cloarec, MD
• Affiliation: Association Nationale de Prevention Medicale

Key inclusion & exclusion criteria

Inclusion Criteria:

- age 40-75 years

- BMI 18.5-30

- osteoarthritis type II or III

Exclusion Criteria:

- osteoarthritis type I or IV

- allergy to one of the component of the supplement

- blood pressure > 14/8

- history of knee surgery



Age minimum: 40 Years
Age maximum: 75 Years
Gender: Both

Health Condition(s) or Problem(s) studied

Osteoarthritis

Intervention(s)

Dietary Supplement: ARTRONAT

Dietary Supplement: PLACEBO

Primary Outcome(s)

Reduction of gonalgia [Time Frame: T8 months]

Secondary Outcome(s)

Evaluation of the satisfactory relief of symptoms of osteoarthritis at each visit after the beginning of supplementation, assessed by the patients. [Time Frame: T2, T4, T6, T8 months]

Secondary ID(s)

2011-A00319-32

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

RDVC Produit de Santé.

Association Nationale de Prévention Médicale.